North China Pharmaceutical Company.,Ltd.’s Net Profit Dropped 65.9% in First Quarter of 2023

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 6.5 million yuan in the first quarter of 2023, down 65.9% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 4.6% year-on-year.

At the end of the reporting period, it had 21.8 billion yuan in total assets and 15.6 billion yuan in total liabilities, with a liability-to-asset ratio of 71.4%.